Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Fox Chase Cancer Center
Filadelfia, Estados UnidosPublicaciones en colaboración con investigadores/as de Fox Chase Cancer Center (2)
2021
-
OX40 agonist BMS-986178 alone or in combination with nivolumab and/or ipilimumab in patients with advanced solid tumors
Clinical Cancer Research, Vol. 27, Núm. 2, pp. 460-472
2016
-
Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma
Clinical Cancer Research